Cardiovascular Systems Inc., announced today that its CALCIUM 360 deg Study, the first-of-its kind prospective, randomized feasibility study, demonstrated the safety and effectiveness of plaque modification with the Diamondback 360(R) PAD System versus the standard of care treatment (balloon angioplasty) in below-the-knee arteries. This study contributes to a large and growing body of clinical evidence from 1,200 patients in nine clinical trials demonstrating that the Diamondback 360 deg can predictably treat peripheral arterial disease (PAD) safely and effectively anywhere in the leg.
Link:
http://www.csi360.com/diamondback360.html
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment